Bioscribe
Advertising Networks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
102 Edison Ave, Corte Madera, California...Phone Number
(415) 891-3941Website
www.bioscribe.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Bioscribe
Bioscribe is a communications consultancy that specializes in public relations and corporate communications for the life science and biotechnology sectors. They offer a range of services including corporate communications, media strategy, social media management, content development, event planning, advocacy, and marketing communications. Their clients include early-stage companies and established firms in biopharma, life science technologies, and diagnostics, all focused on advancing healthcare innovations. With a senior-level team experienced in both journalism and life sciences, Bioscribe aims to create integrated and scalable communication strategies that align with their clients' growth stages and objectives.Explore more
Bioscribe Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bioscribe your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bioscribe
Website visits: Recent activity has been detected on your website
Check if Bioscribe has recently received funding, and reach out quickly before it becomes old news!
Bioscribe, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Bioscribe has new funding data
Check out if Bioscribe is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Bioscribe launches new products
Click to see if Bioscribe had a recent Job posting/layoffs
Earning: See what the market has to say on Bioscribe recently announced quarterly report
Recommended Actions
Find VP level buyers at Bioscribe
Find more new buyers
Compare Similar Companies to Bioscribe
Compare insights from companies similar to Bioscribe, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bioscribe is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bioscribe is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bioscribe.
Bioscribe Tech Stack
A closer look at the technologies used by Bioscribe
See more technologies
Bioscribe News & Media
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced detailed results of its first-in-human Phase 1 clinical trial of AVB-S6-500 in healthy volunteers. As previously announced, the trial met the safety and tolerability endpoints for the trial and demonstrated clinical proof-of-mechanism for AVB-S6-500 in neutralizing GAS6, a key molecule in the AXL cancer survival pathway. These detailed data are being presented todaSaliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers, Including Children with Developmental Delays
SYRACUSE, N.Y.--(BUSINESS WIRE)--Research validating a saliva-based test for autism published online today in Frontiers in Genetics.Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates
- Merger completed; now operating as Aravive, Inc. (Nasdaq:ARAV), a clinical-stage biopharmaceutical company advancing innovative oncology therapeutics - FDA Fast Track designation granted for lead candidate, AVB-S6-500 - Initiation of the Phase 1b portion of a Phase 1b/2 clinical trial of AVB-S6-500 in patients with platinum-resistant recurrent ovarian cancer expected before the end of 2018Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers on the Path from Autism Diagnosis to Early Intervention
SYRACUSE, N.Y.--(BUSINESS WIRE)--Quadrant Biosciences Teams Up with Autism Speaks
Read more news
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bioscribe
Sign Up For FreeTo access detailed company insights
Bioscribe is a communications consultancy that specializes in public relations and corporate communications for the life science and biotechnology sectors. They offer a range of services including corporate communications, media strategy, social media management, content development, event planning, advocacy, and marketing communications. Their cli... Read More
